Mirae Asset Global ETFs Holdings’s Definium Therapeutics DFTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$873K	Buy	46,193 +2,457	+6%	+$41.7K	﹤0.01%	1579
2025 Q4	$586K	Buy	43,736 +8,339	+24%	+$103K	﹤0.01%	1808
2025 Q3	$417K	Sell	35,397 -5,864	-14%	-$54.7K	﹤0.01%	1949
2025 Q2	$268K	Sell	41,261 -2,289	-5%	-$15.1K	﹤0.01%	2129
2025 Q1	$255K	Sell	43,550 -2,140	-5%	-$15.3K	﹤0.01%	2193
2024 Q4	$318K	Buy	45,690 +6,182	+16%	+$42.5K	﹤0.01%	2139
2024 Q3	$225K	Buy	+39,508	New	+$275K	﹤0.01%	2318

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's DFTX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Definium Therapeutics (DFTX) stake by 5.6% in Q1 2026, buying an estimated $41.7K and bringing the position to 46,193 shares worth $873K. The position accounts for ﹤0.01% of the portfolio, ranked #1579.

Mirae Asset Global ETFs Holdings first reported a position in DFTX in Q3 2024 and has held it in 7 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

Mirae Asset Global ETFs Holdings held 46,193 shares of Definium Therapeutics worth $873K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 2,457 Definium Therapeutics shares in Q1 2026, an estimated $41.7K.
Definium Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1579 holding.
Mirae Asset Global ETFs Holdings first reported a position in Definium Therapeutics in Q3 2024 and has held it in 7 quarters since.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.